The registrational trial is expected to support the approval for Bavarian’s mpox/smallpox vaccine use in children between two ...

Unverified data about events after vaccinations is not evidence that the vaccine caused the event, as suggested in social ...

The trial will be conducted in the Democratic Republic of the Congo in partnership with Emergent BioSolutions.

This is not the case with the vaccine devised to combat smallpox or variola virus. The smallpox vaccine is not a form of variola virus, but a preparation of vaccinia (a form of cowpox) virus.

Emergent BioSolutions has been given FDA approval to extend the indications for its smallpox vaccine ACAM2000 to include the prevention of mpox, currently deemed a public health emergency by the WHO.

Press Release - A drug currently approved for smallpox in the U.S. will undergo clinical trials to treat patients infected by the Mpox viruswho are at risk of severe complications in the Democratic ...

WHO’S SHOWING UP EARLY? Trump had better hope that his—ah— unorthodox appeal to female voters is paying off. Politico reports ...

An update from Tonix Pharma ( (TNXP) ) is now available. Tonix Pharmaceuticals has partnered with the Kenya Medical Research ...

Also Read: Emergent BioSolutions Confirms Orders Worth $400M Related To Smallpox, Mpox Vaccines Revenues from Anthrax MCM ...

Results from this study could support an extension of the current approval of MVA-BN to include children from 2 years of age ...

The Frederick biotechnology company BioFactura has announced $7.8 million in new contract activations to study a treatment for a potential smallpox outbreak. The company has gotten contract option ...

Since December 2020, Lewis and Clark Public Health has administered 47,737 COVID-19 vaccine doses, equal to 33 shots per day, every day in the last four years.